Osaic Holdings’s Nuvation Bio NUVB Stock Holding History

Osaic Holdings’s Portfolio NUVB Stock Details NUVB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$154K	Sell	27,076 -10,431	-28%	-$51K	﹤0.01%	4625
2026 Q1	$161K	Buy	37,507 +431	+1%	+$2.4K	﹤0.01%	4329
2025 Q4	$332K	Buy	37,076 +35,519	+2,281%	+$220K	﹤0.01%	3704
2025 Q3	$5.58K	Sell	1,557 -1,152	-43%	-$3.14K	﹤0.01%	6689
2025 Q2	$5.28K	Buy	2,709 +602	+29%	+$1.25K	﹤0.01%	6515
2025 Q1	$3.71K	Buy	2,107 +740	+54%	+$1.68K	﹤0.01%	6335
2024 Q4	$3.64K	Sell	1,367 -52	-4%	-$134	﹤0.01%	6357
2024 Q3	$3.25K	Sell	1,419 -4,081	-74%	-$12.4K	﹤0.01%	6402
2024 Q2	$16.1K	Buy	5,500 +5,000	+1,000%	+$15.3K	﹤0.01%	5490
2024 Q1	$1.82K	Hold	500	–	–	﹤0.01%	6505
2023 Q4	$755	Hold	500	–	–	﹤0.01%	6830
2023 Q3	$670	Hold	500	–	–	﹤0.01%	6929
2023 Q2	$900	Hold	500	–	–	﹤0.01%	6910
2023 Q1	$830	Hold	500	–	–	﹤0.01%	7015
2022 Q4	$1K	Buy	+500	New	+$1.01K	﹤0.01%	6916

Other funds holding NUVB

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Decheng Capital Menlo Park, California $732M AUM 275.56% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

OFM

Omega Fund Management Boston, Massachusetts $186M AUM 155.23% 1-Year Est. Return

LCM

Laurion Capital Management New York $3.9B AUM 75.03% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

DFO

Duquesne Family Office New York $5.21B AUM 87.01% 1-Year Est. Return

American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

Osaic Holdings's NUVB Position: Q2 2026 in Review

Osaic Holdings reduced its Nuvation Bio (NUVB) stake by 28% in Q2 2026, selling an estimated $51K and leaving 27,076 shares worth $154K. The position accounts for ﹤0.01% of the portfolio, ranked #4625.

Osaic Holdings first reported a position in NUVB in Q4 2022 and has held it in 15 quarters since. The position peaked at $332K in Q4 2025. 244 funds tracked by Wall St. Rank hold NUVB as of Q2 2026.

Osaic Holdings held 27,076 shares of Nuvation Bio worth $154K as of Q2 2026.
Osaic Holdings sold 10,431 Nuvation Bio shares in Q2 2026, an estimated $51K.
Nuvation Bio made up ﹤0.01% of Osaic Holdings's portfolio in Q2 2026, its #4625 holding.
Osaic Holdings first reported a position in Nuvation Bio in Q4 2022 and has held it in 15 quarters since.
Osaic Holdings's Nuvation Bio position peaked at $332K in Q4 2025.
244 funds tracked by Wall St. Rank held Nuvation Bio as of Q2 2026.

Based on Osaic Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.